Acinetobacter baumannii: A Rare Organism Causing Blood Stream Infection in a Five-Year Old Girl in South-East Nigeria
Asian Journal of Case Reports in Medicine and Health, Volume 6, Issue 1,
Page 58-65
Abstract
Aim: Acinetobacter baumannii is an aerobic Gram-negative coccobacilli found in the environment, which causes predominantly nosocomial infections in humans. However, the incidence of community acquired infections is on the increase. It is characterized high resistance to the environment and the ability to develop resistance to commonly prescribed antimicrobials. Its clinical features are non-specific and range from a benign transient bacteremia to fulminant septic shock. Carbapenems are recommended for first line treatment. This series presentation aims to increase awareness of this condition.
Presentation of Cases: A case of a five-year old girl who presented with features suggestive of an upper respiratory tract infection in Enugu State, South-East Nigeria is reported. She also had a history of recent travel to Europe. Serial haematologic investigations showed evidence of worsening bacteremia and blood culture revealed Acinetobacter baumannii. She was managed with intravenous Meroponem and was discharged sixteen days after presentation.
Discussion: In this case, the finding of Acinetobacter baumannii from blood culture followed an initial non response to conventional antibiotics and the history of recent travel to Europe. This organism has hitherto not been isolated in our environment, and is a significant cause of nosocomial infections with high morbidity and mortality. Isolation of this organism requires BACTEC culture methods. Its high resilience and multidrug resistance makes it difficult to treat.
Conclusion: The incidence of community acquired Acinetobacter baumannii is on the increase. Management involves a high index of suspicion, prompt and accurate isolation of infecting strains and the proper choice of antibiotic regimens.
- Multi drug resistance
- community acquired infection
- bacteremia
How to Cite
References
Fleischmann-Struzek C, Goldfarb D, Schlattmann P, Schlapbach L, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: A systematic review. Lancet Respir Med. 2018; 6: 223-230.
Available:https://doi.org/10.1016/S2213-2600(18)30063-8
World Health Organization. Global Report on the Epidemiology and Burden of Sepsis: Current Evidence, Identifying Gaps and Future Directions. World Health Organization, Geneva; 2020.
Available:https://apps.who.int/iris/handle/10665/334216. Accessed: March 05, 2023
Onubogu U. Prevalence of bacteraemia in febrile, under-five children in the children’s outpatient clinic of university of Port-Harcourt teaching hospital, Port Harcourt, Nigeria. Niger J Paed 2015; 42 (2): 93 –97.
DOI:http://dx.doi.org/10.4314/njp.v42i2.4
Kabara H, Hassan-Hanga F, Abdusalam K, Sarkinfada F, Kabir H, Mohammed M, et al. Sepsis incidence, outcome and correlates in regional tertiary hospital in Kano, northwestern Nigeria. Crit Care Med. 2019;47(1): 805.
DOI:10.1097/01.ccm.0000552401.15517.3e.
Ogunkunle, T, Abdulkadir M, Katibi O, Bello S, Raheem R, Olaosebikan R. Pediatric blood culture isolates and antibiotic sensitivity pattern in a Nigerian tertiary hospital. Niger J Med. 2020; 29(2): 261-4.
DOI: 10.4103/NJM.NJM_55_20.
Patil R, Kabera B, Muia C, Ale B. Hospital acquired infections in a private paediatric hospital in Kenya: A retrospective cross-sectional study. Pan Afr Med J. 2022;11:41:28.
DOI: 10.11604/pamj.2022.41.28.25820. PMID: 35291367; PMCID: PMC8895558.
Lin M, Lan C. Antimicrobial resistance in Acinetobacter baumannii: from bench to bedside. World J. Clin. Cases. 2014; 2: 787–814.
DOI: 10.12998/wjcc.v2.i12.787.
Howard A, O'Donoghue M, Feeney A, Sleator RD. Acinetobacter baumannii: An emerging opportunistic pathogen. Virulence. 2012;3(3):243-50.
DOI: 10.4161/viru.19700. Epub 2012 May 1. PMID: 22546906; PMCID: PMC3442836
Ballouz T, Aridi J, Afif C, Irani J, Lakis C, Nasreddine R, et al. Risk factors, clinical presentation, and outcome of Acinetobacter baumannii bacteremia. Front Cell Infect Microbiol. 2017;7:156.
DOI: 10.3389/fcimb.2017.00156. PMID: 28523249; PMCID: PMC5415554.
Cisneros J, Rodruguez- Baño J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect. 2002;8(11):687-693. DOI:https://doi.org/10.1046/j.1469-0691.2002.00487.x
Chopra T, Marchaim D, Awali RA, Krishna A, Johnson P, Tansek R, Chaudary K, Lephart P, Slim J, Hothi J, Ahmed H, Pogue JM, Zhao JJ, Kaye KS. Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes. Antimicrob Agents Chemother. 2013;57(12):6270-5.
DOI: 10.1128/AAC.01520-13. Epub 2013 Oct 7. PMID: 24100492; PMCID: PMC3837851.
Nasr P. Genetics, epidemiology, and clinical manifestations of multidrug-resistant Acinetobacter baumannii. J Hosp Infect. 2020; 104 (1): 1-4.
Available:https://doi.org/10.1016/j.jhin.2019.09.021
Lee C, Lee J, Park M, Park K, Bae I, Kim Y, et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol. 2017;7:55.
DOI: 10.3389/fcimb.2017.00055. PMID: 28348979; PMCID: PMC5346588
Montefour K, Frieden J, Hurst S, Helmich C, Headley D, Martin M, et al. Acinetobacter baumannii: An emerging multidrug-resistant pathogen in critical care. Crit Care Nurse. 2008;28: 15–25.
Peleg A, Seifert H, Paterson D. Acinetobacter baumannii: Emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3).
DOI: https://doi.org/10.1128/CMR.000 58-07
Turton JF, Kaufmann ME, Gill MJ, Pike R, Scott PT, Fishbain J, et al. Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict. J Clin Microbiol. 2006;44:2630–4.
DOI: 10.1128/JCM.00547-06.
World Health Organization. Prevention of hospital-acquired infections: A practical guide / editors: G. Ducel, J. Fabry and L. Nicolle, 2nd. Ed. World Health Organization; 2002.
Available:https://apps.who.int/iris/handle/10665/67350. Accessed: March 12; 2023.
C-reactive protein concentrations as a marker of inflammation or infection for interpreting biomarkers of micronutrient status. Vitamin and Mineral Nutrition Information System. Geneva: World Health Organization; 2014 (WHO/NMH/NHD/ EPG/14.7)
Available:http://apps.who.int/iris/bitstream/10665/133708/1/WHO
NMH_NHD_EPG_14.7_eng.pdf?ua=1.
Available: https://www.who.int/publications-detail-redirect/WHO-NMH-NHD-EPG-14.7. Accessed: March 12, 2023.
Sleiman E, Upadhyaya A, Glaser A, Krzyzal M. A case of Plasmodium falciparum malaria with a prolonged incubation period of four years. Cureus. 2020;12(3):e7176.
DOI:10.7759/cureus.7176.
World Health Organization. Global antimicrobial resistance surveillance system: manual for early implementation. World Health Organization; 2015.
Available:https://apps.who.int/iris/handle/10665/188783. License: CC BY-NC-SA 3.0 IGO.
Available:https://apps.who.int/iris/bitstream/handle/10665/188783/9789241549400_eng.pdf. Accessed March 20, 2023.
Onyemelukwe N, Ohanu M, Nwokocha A. Susceptibility pattern of nasopharyngeal isolates of streptococcus pneumoniae among nursery school children in Enugu, Nigeria. Int J Med Health Dev. 2002;7 (2):74-6.
Ughasoro M, Akpeh J, Echendu N, Mgbachi N, Okpala S, Amah L, et al. The profile of microorganisms that associate with acute tonsillitis in children and their antibiotics sensitivity pattern in Nigeria. Sci Rep. 2021;11(1):20084.
DOI: 10.1038/s41598-021-99570-9. PMID: 34635755; PMCID: PMC8505406
-
Abstract View: 6 times
PDF Download: 1 times
